Track topics on Twitter Track topics that are important to you
Biogen is one those companies, like Sanofi until its recent Bioverativ acquisition, that has real pressure to make a big acquisition. Now that the tax incentives to bring money over from abroad have been brought through, the pressure just ramped up for the biotech.
Not least, because of the aforementioned Sanofi deal and the Celgene deal that were also announced on the same day – the excitement around M&A potentially gearing up again has many people excited and that’s bound to have more eyes focused on the moves Biogen could make.
Original Article: Biogen announces acquisition along with financials, but it’s tinyNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...